Cargando…

FFA2-, but not FFA3-agonists inhibit GSIS of human pseudoislets: a comparative study with mouse islets and rat INS-1E cells

The expression of short chain fatty acid receptors FFA2 and FFA3 in pancreatic islets raised interest in using them as drug targets for treating hyperglycemia in humans. This study aims to examine the efficacy of synthetic FFA2- and FFA3-ligands to modulate glucose-stimulated insulin secretion (GSIS...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorza-Gil, Estela, Kaiser, Gabriele, Rexen Ulven, Elisabeth, König, Gabriele M., Gerst, Felicia, Oquendo, Morgana Barroso, Birkenfeld, Andreas L., Häring, Hans-Ulrich, Kostenis, Evi, Ulven, Trond, Ullrich, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536384/
https://www.ncbi.nlm.nih.gov/pubmed/33020504
http://dx.doi.org/10.1038/s41598-020-73467-5
_version_ 1783590555066826752
author Lorza-Gil, Estela
Kaiser, Gabriele
Rexen Ulven, Elisabeth
König, Gabriele M.
Gerst, Felicia
Oquendo, Morgana Barroso
Birkenfeld, Andreas L.
Häring, Hans-Ulrich
Kostenis, Evi
Ulven, Trond
Ullrich, Susanne
author_facet Lorza-Gil, Estela
Kaiser, Gabriele
Rexen Ulven, Elisabeth
König, Gabriele M.
Gerst, Felicia
Oquendo, Morgana Barroso
Birkenfeld, Andreas L.
Häring, Hans-Ulrich
Kostenis, Evi
Ulven, Trond
Ullrich, Susanne
author_sort Lorza-Gil, Estela
collection PubMed
description The expression of short chain fatty acid receptors FFA2 and FFA3 in pancreatic islets raised interest in using them as drug targets for treating hyperglycemia in humans. This study aims to examine the efficacy of synthetic FFA2- and FFA3-ligands to modulate glucose-stimulated insulin secretion (GSIS) in human pseudoislets which display intact glucose responsiveness. The FFA2-agonists 4-CMTB and TUG-1375 inhibited GSIS, an effect reversed by the FFA2-antagonist CATPB. GSIS itself was not augmented by CATPB. The FFA3-agonists FHQC and 1-MCPC did not affect GSIS in human pseudoislets. For further drug evaluation we used mouse islets. The CATPB-sensitive inhibitory effect of 100 µM 4-CMTB on GSIS was recapitulated. The inhibition was partially sensitive to the G(i/o)-protein inhibitor pertussis toxin. A previously described FFA2-dependent increase of GSIS was observed with lower concentrations of 4-CMTB (10 and 30 µM). The stimulatory effect of 4-CMTB on secretion was prevented by the Gq-protein inhibitor FR900359. As in human pseudoislets, in mouse islets relative mRNA levels were FFAR2 > FFAR3 and FFA3-agonists did not affect GSIS. The FFA3-agonists, however, inhibited GSIS in a pertussis toxin-sensitive manner in INS-1E cells and this correlated with relative mRNA levels of Ffar3 > > Ffar2. Thus, in humans, when FFA2-activation impedes GSIS, FFA2-antagonism may reduce glycemia.
format Online
Article
Text
id pubmed-7536384
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-75363842020-10-07 FFA2-, but not FFA3-agonists inhibit GSIS of human pseudoislets: a comparative study with mouse islets and rat INS-1E cells Lorza-Gil, Estela Kaiser, Gabriele Rexen Ulven, Elisabeth König, Gabriele M. Gerst, Felicia Oquendo, Morgana Barroso Birkenfeld, Andreas L. Häring, Hans-Ulrich Kostenis, Evi Ulven, Trond Ullrich, Susanne Sci Rep Article The expression of short chain fatty acid receptors FFA2 and FFA3 in pancreatic islets raised interest in using them as drug targets for treating hyperglycemia in humans. This study aims to examine the efficacy of synthetic FFA2- and FFA3-ligands to modulate glucose-stimulated insulin secretion (GSIS) in human pseudoislets which display intact glucose responsiveness. The FFA2-agonists 4-CMTB and TUG-1375 inhibited GSIS, an effect reversed by the FFA2-antagonist CATPB. GSIS itself was not augmented by CATPB. The FFA3-agonists FHQC and 1-MCPC did not affect GSIS in human pseudoislets. For further drug evaluation we used mouse islets. The CATPB-sensitive inhibitory effect of 100 µM 4-CMTB on GSIS was recapitulated. The inhibition was partially sensitive to the G(i/o)-protein inhibitor pertussis toxin. A previously described FFA2-dependent increase of GSIS was observed with lower concentrations of 4-CMTB (10 and 30 µM). The stimulatory effect of 4-CMTB on secretion was prevented by the Gq-protein inhibitor FR900359. As in human pseudoislets, in mouse islets relative mRNA levels were FFAR2 > FFAR3 and FFA3-agonists did not affect GSIS. The FFA3-agonists, however, inhibited GSIS in a pertussis toxin-sensitive manner in INS-1E cells and this correlated with relative mRNA levels of Ffar3 > > Ffar2. Thus, in humans, when FFA2-activation impedes GSIS, FFA2-antagonism may reduce glycemia. Nature Publishing Group UK 2020-10-05 /pmc/articles/PMC7536384/ /pubmed/33020504 http://dx.doi.org/10.1038/s41598-020-73467-5 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Lorza-Gil, Estela
Kaiser, Gabriele
Rexen Ulven, Elisabeth
König, Gabriele M.
Gerst, Felicia
Oquendo, Morgana Barroso
Birkenfeld, Andreas L.
Häring, Hans-Ulrich
Kostenis, Evi
Ulven, Trond
Ullrich, Susanne
FFA2-, but not FFA3-agonists inhibit GSIS of human pseudoislets: a comparative study with mouse islets and rat INS-1E cells
title FFA2-, but not FFA3-agonists inhibit GSIS of human pseudoislets: a comparative study with mouse islets and rat INS-1E cells
title_full FFA2-, but not FFA3-agonists inhibit GSIS of human pseudoislets: a comparative study with mouse islets and rat INS-1E cells
title_fullStr FFA2-, but not FFA3-agonists inhibit GSIS of human pseudoislets: a comparative study with mouse islets and rat INS-1E cells
title_full_unstemmed FFA2-, but not FFA3-agonists inhibit GSIS of human pseudoislets: a comparative study with mouse islets and rat INS-1E cells
title_short FFA2-, but not FFA3-agonists inhibit GSIS of human pseudoislets: a comparative study with mouse islets and rat INS-1E cells
title_sort ffa2-, but not ffa3-agonists inhibit gsis of human pseudoislets: a comparative study with mouse islets and rat ins-1e cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536384/
https://www.ncbi.nlm.nih.gov/pubmed/33020504
http://dx.doi.org/10.1038/s41598-020-73467-5
work_keys_str_mv AT lorzagilestela ffa2butnotffa3agonistsinhibitgsisofhumanpseudoisletsacomparativestudywithmouseisletsandratins1ecells
AT kaisergabriele ffa2butnotffa3agonistsinhibitgsisofhumanpseudoisletsacomparativestudywithmouseisletsandratins1ecells
AT rexenulvenelisabeth ffa2butnotffa3agonistsinhibitgsisofhumanpseudoisletsacomparativestudywithmouseisletsandratins1ecells
AT koniggabrielem ffa2butnotffa3agonistsinhibitgsisofhumanpseudoisletsacomparativestudywithmouseisletsandratins1ecells
AT gerstfelicia ffa2butnotffa3agonistsinhibitgsisofhumanpseudoisletsacomparativestudywithmouseisletsandratins1ecells
AT oquendomorganabarroso ffa2butnotffa3agonistsinhibitgsisofhumanpseudoisletsacomparativestudywithmouseisletsandratins1ecells
AT birkenfeldandreasl ffa2butnotffa3agonistsinhibitgsisofhumanpseudoisletsacomparativestudywithmouseisletsandratins1ecells
AT haringhansulrich ffa2butnotffa3agonistsinhibitgsisofhumanpseudoisletsacomparativestudywithmouseisletsandratins1ecells
AT kostenisevi ffa2butnotffa3agonistsinhibitgsisofhumanpseudoisletsacomparativestudywithmouseisletsandratins1ecells
AT ulventrond ffa2butnotffa3agonistsinhibitgsisofhumanpseudoisletsacomparativestudywithmouseisletsandratins1ecells
AT ullrichsusanne ffa2butnotffa3agonistsinhibitgsisofhumanpseudoisletsacomparativestudywithmouseisletsandratins1ecells